logo
Embracing AI: The New Imperative For Modern Journalism

Embracing AI: The New Imperative For Modern Journalism

Barnama12 hours ago

GENERAL
By Suraidah Roslan
KUALA LUMPUR, June 6 (Bernama) -- In a world increasingly driven by artificial intelligence (AI), journalists must quickly adapt and embrace the technology, not only to remain relevant but to redefine efficiency and excellence in their work.
In conjunction with National Journalists' Day (HAWANA) 2025, Malaysian National News Agency (Bernama) journalist Marfika Adnan Haris Fadzilah, 34, shared her experience participating in the 2024 China International Media Exchange Programme, organised by the China International Press Communication Centre in Beijing.
Marfika, a journalist with Bernama's Lifestyle Desk, said that during her four-month stint in China, she saw how deeply AI was woven into daily life and how it proved useful to her as well.
'AI became a part of my daily routine in China, not just as a work tool, but as a personal assistant that just made life easier,' she said.
Among the AI applications she found indispensable were Baidu Translate and WeChat Translate, which let her instantly convert Chinese documents into Malay or English using just her phone.
She acknowledged that she relied heavily on ChatGPT throughout her four-month assignment, using it to craft interview questions, write photo captions and translate Chinese texts into Malay or English.
Reflecting on the challenges she faced in China, Marfika said the language barrier was the most difficult, as most locals had limited proficiency in English.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm
ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm

Malaysian Reserve

time2 hours ago

  • Malaysian Reserve

ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm

NEW YORK, June 6, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the 'Registration Statement') issued in connection with Zenas BioPharma's September 2024 initial public offering ('IPO' or the 'Offering'), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So What: If you purchased Zenas BioPharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Zenas BioPharma class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Zenas BioPharma action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@

US-China trade talks to resume in seven days: White House
US-China trade talks to resume in seven days: White House

New Straits Times

time6 hours ago

  • New Straits Times

US-China trade talks to resume in seven days: White House

WASHINGTON: Trade negotiations between US and Chinese officials are expected to resume within seven days, following a phone call between President Donald Trump and President Xi Jinping. The discussions will place particular emphasis on rare earth minerals, White House Trade Adviser Peter Navarro confirmed on Friday. "We expect that a meeting will take place within seven days," Navarro told reporters at the White House, commenting on the timeline of the next round of trade talks. Navarro stated that Trump has been clear that "the rare earth issue will be key to that negotiation", as reported by Sputnik/RIA Novosti. The US delegation will include Trade Representative Jamieson Greer, Treasury Secretary Scott Bessent, and Secretary of Commerce Howard Lutnick, according to Navarro. The advisor also mentioned that Thursday's call between Trump and Xi lasted approximately 90 minutes, during which both leaders demonstrated "a very clear understanding" of the expected outcomes of the upcoming discussions. Trump later shared on Truth Social that he had discussed "some of the intricacies" of the US-China trade deal with President Xi. He also announced that he had accepted Xi's invitation to visit China and extended a reciprocal invitation. Following high-level trade and economic talks in Geneva earlier in May, Washington and Beijing agreed to lower reciprocal tariffs by 115 percentage points each for 90 days. The US has reduced tariffs on Chinese goods from 145 per cent to 30 per cent, while China has cut tariffs on American imports from 125 per cent to 10 per cent. Later that month, Trump accused China of "totally violating" the Geneva agreement and remarked that "it is extremely hard" to reach a deal with Beijing.–BERNAMA

MCMC Clarifies Mobile Phone Data Collection Amid Media Reports, Ensures Privacy
MCMC Clarifies Mobile Phone Data Collection Amid Media Reports, Ensures Privacy

Barnama

time6 hours ago

  • Barnama

MCMC Clarifies Mobile Phone Data Collection Amid Media Reports, Ensures Privacy

KUALA LUMPUR, June 6 (Bernama) -- The Malaysian Communications and Multimedia Commission (MCMC) has clarified its collection of mobile phone data (MPD) from Mobile Network Operators (MNOs), assuring that no Personally Identifiable Information (PII) is accessed, processed, or disclosed. The clarification comes amid recent media reports regarding the matter. In a statement today, MCMC said MPD was used strictly for the generation of official statistics to support evidence-based policymaking in two key domains, namely the ICT Sector and the Tourism Sector. For the ICT Sector, MPD helps produce granular statistics, such as the number of active mobile broadband subscriptions and penetration rates at the state, district, mukim, parliamentary constituency, state legislative assembly (DUN), and local authority levels. For the Tourism Sector, it generates indicators such as the number of visitors and domestic tourism trips. 'The MPD data requested from MNOs is anonymised and contains no PII. 'In addition, MNOs are given the option to either process the MPD data within their own secure environment and submit the required anonymised and aggregated output to MCMC, or, for MNOs without in-house processing capabilities, to submit the anonymised data to MCMC for processing. 'In both cases, no individual subscriber can be identified through the data collected,' it said. MCMC further clarified that the use of MPD as a new source of national statistics was a strategic direction set by the government to strengthen the quality and timeliness of statistical outputs for policy and planning purposes. Implementation of MPD is through collaboration with the International Telecommunication Union (ITU) and the UN Committee of Experts on Big Data and Data Science, it added. Over the past two years, MCMC said extensive engagement with all MNOs had been carried out to ensure mutual understanding of the data requirements, processes, and privacy safeguards.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store